![]() |
市場調查報告書
商品編碼
1746617
日本周邊血管設備市場報告(按設備類型、最終用戶和地區)2025-2033Japan Peripheral Vascular Devices Market Report by Device Type, End User, and Region 2025-2033 |
2024年,日本周邊血管器械市場規模達5.481億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到10.162億美元,2025-2033年期間的複合年成長率(CAGR)為6.6%。微創手術因其住院時間短、恢復速度快等特點,其應用日益廣泛,成為推動市場成長的主要動力。
周邊血管疾病 (PVD) 是一種由心臟和腦外血管收縮、阻塞或痙攣引起的循環系統疾病。這些疾病會導致血管內血流減少,進而引發虛弱、不適、壞疽、腿部脫髮、麻木和肌肉疲勞等症狀。為了治療動脈阻塞和狹窄,醫護人員會使用周邊血管裝置,包括血管成形術導管、周邊導絲、腔靜脈濾器、支架移植物和栓塞保護裝置 (EPD)。周邊血管阻塞主要是由斑塊堆積引起的,斑塊會收縮血管,阻礙血液流向身體各部位。周邊血管裝置是一種安全的解決方案,可最大限度地降低感染和刺激的風險,同時增強血流並透過動脈輸送富氧血液。
日本周邊血管疾病市場正呈現良好發展軌跡,這主要得益於全球靜脈注射疾病(包括慢性靜脈功能不全 (CVI))的盛行率不斷上升。周邊血管裝置在確保腦部、腿部和足部等關鍵部位獲得充足血流,從而維持最佳身體機能方面發揮關鍵作用。日本老化人口的不斷成長以及周邊動脈疾病 (PAD) 和動脈阻塞等各種疾病發病率的激增,是導致這一上升趨勢的原因之一。吸煙、過量飲酒、缺乏運動和不健康的飲食等生活方式因素在這些健康問題中扮演著重要角色。微創手術 (MIS) 因其併發症少、術後不適感減輕、住院時間短和恢復時間快等優勢,日益受到青睞,進一步提振了市場。此外,由於動脈粥狀硬化、肥胖症和生活型態相關疾病的盛行率不斷上升,動脈粥狀硬化切除設備的普及率也不斷上升。日本的醫療保健產業正經歷大幅成長,消費者的消費能力不斷增強,研發投入也不斷增加。這些因素共同造就了日本周邊血管疾病市場的樂觀前景,確保其在預測期內持續成長和發展。
市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外,報告還提供了所有主要公司的詳細資料。
Japan peripheral vascular devices market size reached USD 548.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,016.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.6% during 2025-2033. The growing usage of minimally invasive surgeries, as they require shortened hospital stay and have faster recovery, is primarily driving the market growth.
Peripheral vascular disease (PVD) is a circulatory ailment resulting from the constriction, obstruction, or spasms in blood vessels situated outside the heart and brain. These occurrences lead to a diminished blood flow within these vessels, resulting in symptoms like weakness, discomfort, gangrene, leg hair loss, numbness, and muscle fatigue. To address artery blockages and narrowing, healthcare professionals utilize peripheral vascular devices, including angioplasty catheters, peripheral guidewires, vena cava filters, stent grafts, and embolic protection devices (EPD). Blockages in the peripheral vasculature, in particular, are primarily caused by the accumulation of plaque, which constricts the blood vessels and hampers blood circulation to various body regions. Peripheral vascular devices are a secure solution that minimizes the risk of infection and irritation while enhancing blood flow and supplying oxygen-rich blood through the arteries.
The Japan peripheral vascular disease market is experiencing a promising trajectory, primarily due to the escalating prevalence of venous diseases, including chronic venous insufficiency (CVI) on a global scale. Peripheral vascular devices play a pivotal role in ensuring adequate blood flow to critical regions like the brain, legs, and feet, thus enabling optimal bodily functions. Contributing to this upward trend is the growing aging population in Japan and the surging incidence of various conditions such as peripheral artery disease (PAD) and arterial blockages. Lifestyle factors, including smoking, excessive alcohol consumption, physical inactivity, and unhealthy dietary choices, have played a significant role in these health issues. The market is further bolstered by the increasing preference for minimally invasive surgeries (MIS), driven by their advantages such as reduced complications, decreased postoperative discomfort, shorter hospital stays, and quicker recovery times. Additionally, the widespread adoption of atherectomy devices is on the rise due to the increasing prevalence of atherosclerosis, obesity, and lifestyle-related disorders. The healthcare sector in Japan is witnessing substantial growth, with consumers having greater spending capacity and increased investment in research and development (R&D) activities. These factors collectively contribute to a positive outlook for the Japan peripheral vascular disease market, ensuring its continued growth and development, over the forecasted period.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.